Search alternatives:
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
force decrease » fold decrease (Expand Search), forces increased (Expand Search)
fold increased » fold increase (Expand Search)
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
force decrease » fold decrease (Expand Search), forces increased (Expand Search)
fold increased » fold increase (Expand Search)
-
2361
-
2362
-
2363
-
2364
ROS, K<sup>+</sup> efflux and cathepsin B are required for NLRP3 activation.
Published 2025Subjects: -
2365
-
2366
-
2367
-
2368
Differences in health-related quality of life indexes after disease onset between groups.
Published 2025Subjects: -
2369
Changes in subcutaneous fat thickness and muscle mass (Approximately here).
Published 2025Subjects: -
2370
-
2371
-
2372
Ba/F3 EML4-ALK<sup>mutants</sup> exhibit variable dose-response to ABT-199 treatment.
Published 2025Subjects: -
2373
-
2374
-
2375
-
2376
-
2377
-
2378
-
2379
-
2380
Molecular docking showed that ABT-199 can fit into active site of ALK<sup>Mutant</sup>.
Published 2025Subjects: